News

NHS England: Pharma transparency scheme ‘does not go far enough’

By 2016-07-06T11:29:00

Generic drugs

Source: Evgeny Rannev

NHS England says pharma firms’ new transparency scheme ”does not go far enough” because it relies on voluntary disclosure by clinicians of payments received

You need to be a subscriber to read more

HSJ

Subscribe for unlimited access

With a HSJ subscription you’ll unlock:

  • All HSJ news by sector, topic & region
  • Breaking News announcements
  • App for mobile and offline reading
  • Comment and Daily Insights newsletters
  • Regional roundup newsletters
  • Unrestricted access to ‘Ask HSJ’ - AI assistant - AI assistant
  • 10 expert briefings every fortnight (Premium only)

Subscribe

to HSJ

Already a subscriber? Sign into your account here